Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by wildbird1


V.TLT

RE:RE:RE:RE:RE:RE:RE:For those of you

FGPstock wrote:   wild1, if big pharma knew the potential of this...

October 4, 2023

V.TLT

RE:RE:RE:RE:RE:For those of you

Rumpl3StiltSkin wrote: I have to say FGP, Big is probably correct. PDCs are...

October 4, 2023

V.TLT

Waiting for a better opportunities...

"Merck" has a market cap of $272.Billion US. "Merck" has...

September 18, 2023

V.TLT

RE:Adstiladrin has BlockBuster Potential...

Forgot a very important detail, a big pharma will only sign a deal after the...

September 17, 2023

V.TLT

Adstiladrin has BlockBuster Potential...

In this link... https://fiercepharma.com/pharma/ferring-inks-500m-deal...

September 17, 2023

V.TLT

RE:RE:RE:RE:RE:Here's a thought

Eoganacht, here is what I found after googling "Non-Brokered private...

September 14, 2023

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Polish Researchers Cite Rutherrin PDT for Brain Cancer

Benedictus wrote: I revisited that June PR, linked below,  to re-read...

September 13, 2023

V.TLT

The word UPDATE...

Sometime a single word make's a lot's of difference. In the Aug 29...

September 11, 2023

V.TLT

The best approved treatment...

If you want to know if a treatment is good enough for BTD approval, you...

September 8, 2023

V.TLT

TLT & the FDA...

The most interesting part of the last update is not the CR% numbers(although...

August 31, 2023

V.TLT

RE:RE:Interim Data...

DJDawg wrote: Based on what is pending and how hard it can be to move the...

August 28, 2023

V.TLT

Interim Data...

Last year the update was on August 29,2022 The interim data for August 29...

August 28, 2023

V.TLT

RE:RE:New Deal for Adstiladrin

enriquesuave wrote: Basically paying upfront  $500 Million for 5.1% and...

August 26, 2023

V.TLT

RE:RE:RE:Small correction to table

enriquesuave wrote: Could the FDA be considering to give AA for Ruvidar...

August 25, 2023

V.TLT

RE:Small correction to table

DJDawg thank's for the interesting numbers. Let's compare N-803+BCG ...

August 25, 2023

V.TLT

Surrogate Endpoint...

As we speak the big question is...Does Ruvidar(TLD-1433) has the criterias...

August 22, 2023

V.TLT

RE:RE:Principal investigator...

Skys1, thank's for the clarification, I should have said " R...

August 20, 2023

V.TLT

Principal investigator...

Every time the price goes down, the same group of peoples start to talk about...

August 20, 2023

V.TLT

RE:RE:RE:Suspicious trading

In " The Brian Crombie Hour" video with R.Dumoulin(July 6,2023), in...

August 17, 2023

V.TLT

RE:RE:RE:RE:RE:RE:Photodynamic Therapy Market to grow at a CAGR of 8.22%

The $300K came from the May 18, 2023 presentation.Page 22. $200K US=$300K Can...

August 13, 2023